<VariationArchive VariationID="434252" VariationName="NM_000384.3(APOB):c.10238del (p.Thr3413fs)" VariationType="Deletion" Accession="VCV000434252" Version="22" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2017-08-28" MostRecentSubmission="2024-05-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="427986" VariationID="434252">
      <GeneList>
        <Gene Symbol="APOB" FullName="apolipoprotein B" GeneID="338" HGNC_ID="HGNC:603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="21001429" stop="21044073" display_start="21001429" display_stop="21044073" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NW_025791767.1" start="52097" stop="94741" display_start="52097" display_stop="94741" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="21224300" stop="21266944" display_start="21224300" display_stop="21266944" Strand="-" />
          </Location>
          <OMIM>107730</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APOB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=APOB">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000384.3(APOB):c.10238del (p.Thr3413fs)</Name>
      <CanonicalSPDI>NC_000002.12:21006629:G:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="21006630" stop="21006630" display_start="21006630" display_stop="21006630" variantLength="1" positionVCF="21006629" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="21229502" stop="21229502" display_start="21229502" display_stop="21229502" variantLength="1" positionVCF="21229501" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>T3413fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.21229502del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.21229502del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.21006630del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.21006630del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011793.1" sequenceAccession="NG_011793" sequenceVersion="1" change="g.42444del">
            <Expression>NG_011793.1:g.42444del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000384.3" sequenceAccession="NM_000384" sequenceVersion="3" change="c.10238del" MANESelect="true">
            <Expression>NM_000384.3:c.10238del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000375.3" sequenceAccession="NP_000375" sequenceVersion="3" change="p.Thr3413fs">
            <Expression>NP_000375.3:p.Thr3413fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000384.3" sequenceAccession="NM_000384" sequenceVersion="3" change="c.10238del" MANESelect="true">
            <Expression>NM_000384.3(APOB):c.10238del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000384.2" sequenceAccession="NM_000384" sequenceVersion="2" change="c.10238delC">
            <Expression>NM_000384.2:c.10238delC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA042812" DB="ClinGen" />
        <XRef Type="rs" ID="756209187" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00003" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000384.3(APOB):c.10238del (p.Thr3413fs) AND Hypobetalipoproteinemia" Accession="RCV000501647" Version="14">
        <ClassifiedConditionList TraitSetID="22773">
          <ClassifiedCondition DB="MedGen" ID="C0020597">Hypobetalipoproteinemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2016-04-29" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000384.3(APOB):c.10238del (p.Thr3413fs) AND Familial hypobetalipoproteinemia 1" Accession="RCV001248960" Version="11">
        <ClassifiedConditionList TraitSetID="12438">
          <ClassifiedCondition DB="MedGen" ID="C4551990">Familial hypobetalipoproteinemia 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-22" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000384.3(APOB):c.10238del (p.Thr3413fs) AND multiple conditions" Accession="RCV001837939" Version="13">
        <ClassifiedConditionList TraitSetID="19838">
          <ClassifiedCondition DB="MedGen" ID="C4551990">Familial hypobetalipoproteinemia 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1704417">Hypercholesterolemia, autosomal dominant, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000384.3(APOB):c.10238del (p.Thr3413fs) AND not provided" Accession="RCV001783000" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000384.3(APOB):c.10238del (p.Thr3413fs) AND Cardiovascular phenotype" Accession="RCV004023361" Version="1">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000384.3(APOB):c.10238del (p.Thr3413fs) AND Hypercholesterolemia, autosomal dominant, type B" Accession="RCV004554792" Version="1">
        <ClassifiedConditionList TraitSetID="6353">
          <ClassifiedCondition DB="MedGen" ID="C1704417">Hypercholesterolemia, autosomal dominant, type B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-14" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-13" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2017-08-28" MostRecentSubmission="2024-05-19">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1431583</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20032471</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32719484</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33454241</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/9cfbefb4-a92f-4c78-8c5a-f2cc721f940b</URL>
        </Citation>
        <DescriptionHistory Dated="2022-02-01">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="22773" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34352" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypobetalipoproteinemia</ElementValue>
                <XRef ID="HP:0003563" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0017774" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18802" />
                <XRef ID="18802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="31154" DB="Orphanet" />
              <XRef ID="C0020597" DB="MedGen" />
              <XRef ID="MONDO:0017774" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="12438" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18459" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial hypobetalipoproteinemia 1</ElementValue>
                <XRef ID="MONDO:0014252" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypobetalipoproteinemia, normotriglyceridemic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acanthocytosis with hypobetalipoproteinemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHBL1</ElementValue>
                <XRef Type="MIM" ID="615558" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHBL</ElementValue>
                <XRef Type="MIM" ID="615558" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2876" />
                <XRef ID="2876" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with biallelic APOB-related familial hypobetalipoproteinemia (APOB-FHBL) may present from infancy through to adulthood with a range of clinical symptoms including deficiency of fat-soluble vitamins and gastrointestinal and neurologic dysfunction. Affected individuals typically have plasma total cholesterol, LDL cholesterol, and apo B levels below the fifth centile for age and sex. Acanthocytosis, elevated liver enzymes, and hyperbilirubinemia may also be found. The most common clinical findings are hepatomegaly, steatorrhea, and failure to thrive / growth deficiency. In the absence of treatment, affected individuals can develop atypical pigmentation of the retina; progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle pain or weakness; dysarthria; ataxia; tremors; and steatohepatitis, fibrosis, and rarely, cirrhosis of the liver. Individuals with a heterozygous, typically truncating pathogenic variant in APOB are usually asymptomatic with mild liver dysfunction and hepatic steatosis. However, about 5%-10% of individuals with heterozygous APOB-FHBL develop relatively more severe nonalcoholic steatohepatitis requiring medical attention and occasionally progressing to cirrhosis, albeit very rarely.</Attribute>
                <XRef ID="NBK570370" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33983694</ID>
                <ID Source="BookShelf">NBK570370</ID>
              </Citation>
              <XRef ID="C4551990" DB="MedGen" />
              <XRef ID="MONDO:0014252" DB="MONDO" />
              <XRef Type="MIM" ID="615558" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6353" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1725" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type IIb</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypercholesterolemia, autosomal dominant, type B</ElementValue>
                <XRef ID="MONDO:0007751" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Hypercholesterolemia Type B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">APOLIPOPROTEIN B-100, FAMILIAL DEFECTIVE</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APOLIPOPROTEIN B-100, FAMILIAL LIGAND-DEFECTIVE</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FHCL2</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8588" />
                <XRef ID="8588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">APOB-Related Familial Hypercholesterolemia, Autosomal Dominant</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="C1704417" DB="MedGen" />
              <XRef ID="MONDO:0007751" DB="MONDO" />
              <XRef Type="MIM" ID="144010" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="19838" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1725" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HYPERCHOLESTEROLEMIA, FAMILIAL, DUE TO LIGAND-DEFECTIVE APOLIPOPROTEIN B</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperlipoproteinemia Type IIb</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypercholesterolemia, autosomal dominant, type B</ElementValue>
                <XRef ID="MONDO:0007751" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Hypercholesterolemia Type B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">APOLIPOPROTEIN B-100, FAMILIAL DEFECTIVE</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">APOLIPOPROTEIN B-100, FAMILIAL LIGAND-DEFECTIVE</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">FHCL2</ElementValue>
                <XRef Type="MIM" ID="144010" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Familial hypercholesterolemia (FH) is characterized by significantly elevated low-density lipoprotein cholesterol (LDL-C) that leads to atherosclerotic plaque deposition in the coronary arteries and proximal aorta at an early age and increases the risk of premature cardiovascular events such as angina and myocardial infarction; stroke occurs more rarely. Xanthomas (cholesterol deposits in tendons) may be visible in the Achilles tendons or tendons of the hands and worsen with age as a result of extremely high cholesterol levels. Xanthelasmas (yellowish, waxy deposits) can occur around the eyelids. Individuals with FH may develop corneal arcus (white, gray, or blue opaque ring in the corneal margin as a result of cholesterol deposition) at a younger age than those without FH. Individuals with a more severe phenotype, often as a result of biallelic variants, can present with very significant elevations in LDL-C (&gt;500 mg/dL), early-onset coronary artery disease (CAD; presenting as early as childhood in some), and calcific aortic valve disease.</Attribute>
                <XRef ID="NBK174884" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8588" />
                <XRef ID="8588" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">APOB-Related Familial Hypercholesterolemia, Autosomal Dominant</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">24404629</ID>
                <ID Source="BookShelf">NBK174884</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia – Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="C1704417" DB="MedGen" />
              <XRef ID="MONDO:0007751" DB="MONDO" />
              <XRef Type="MIM" ID="144010" DB="OMIM" />
            </Trait>
            <Trait ID="18459" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Familial hypobetalipoproteinemia 1</ElementValue>
                <XRef ID="MONDO:0014252" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypobetalipoproteinemia, normotriglyceridemic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acanthocytosis with hypobetalipoproteinemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FHBL1</ElementValue>
                <XRef Type="MIM" ID="615558" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FHBL</ElementValue>
                <XRef Type="MIM" ID="615558" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2876" />
                <XRef ID="2876" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Individuals with biallelic APOB-related familial hypobetalipoproteinemia (APOB-FHBL) may present from infancy through to adulthood with a range of clinical symptoms including deficiency of fat-soluble vitamins and gastrointestinal and neurologic dysfunction. Affected individuals typically have plasma total cholesterol, LDL cholesterol, and apo B levels below the fifth centile for age and sex. Acanthocytosis, elevated liver enzymes, and hyperbilirubinemia may also be found. The most common clinical findings are hepatomegaly, steatorrhea, and failure to thrive / growth deficiency. In the absence of treatment, affected individuals can develop atypical pigmentation of the retina; progressive loss of deep tendon reflexes, vibratory sense, and proprioception; muscle pain or weakness; dysarthria; ataxia; tremors; and steatohepatitis, fibrosis, and rarely, cirrhosis of the liver. Individuals with a heterozygous, typically truncating pathogenic variant in APOB are usually asymptomatic with mild liver dysfunction and hepatic steatosis. However, about 5%-10% of individuals with heterozygous APOB-FHBL develop relatively more severe nonalcoholic steatohepatitis requiring medical attention and occasionally progressing to cirrhosis, albeit very rarely.</Attribute>
                <XRef ID="NBK570370" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33983694</ID>
                <ID Source="BookShelf">NBK570370</ID>
              </Citation>
              <XRef ID="C4551990" DB="MedGen" />
              <XRef ID="MONDO:0014252" DB="MONDO" />
              <XRef Type="MIM" ID="615558" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1149708" SubmissionDate="2017-07-05" DateLastUpdated="2017-08-28" DateCreated="2017-08-28">
        <ClinVarSubmissionID localKey="NM_000384.2(APOB):c.10238del|Hypobetalipoproteinemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000593264" DateUpdated="2017-08-28" DateCreated="2017-08-28" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.2:c.10238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hypobetalipoproteinemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2843028</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2805170" SubmissionDate="2020-03-09" DateLastUpdated="2022-02-01" DateCreated="2020-07-19">
        <ClinVarSubmissionID localKey="9cfbefb4-a92f-4c78-8c5a-f2cc721f940b|OMIM:615558" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001422759" DateUpdated="2022-02-01" DateCreated="2020-07-19" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/9cfbefb4-a92f-4c78-8c5a-f2cc721f940b</URL>
          </Citation>
          <Comment>The p.Thr3413Metfs variant in APOB has not been previously reported in individuals with low LDL but has been identified in in 0.00155% (2/129014) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs756209187). This variant has also been reported in ClinVar (VariationID: 434252) as pathogenic by the University of Chicago. This variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at position 3413 and leads to a premature termination codon 2 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the APOB gene is an established disease mechanism in autosomal recessive low LDL. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PM2, PVS1 (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Abbrev="ACMG, 2015" Type="practice guideline">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000384.3(APOB):c.10238del</Name>
            <Name>p.Thr3413fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.12:g.21006630del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615558" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6906750</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5457647" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000384.3:c.10238del|OMIM:144010;615558" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810491" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.3:c.10238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="144010" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615558" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3968337" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="3c9ab06f08b02cb86fb6d0d5285ac3fde7d8c1616536eb2303b01cd401277db7|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002018294" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" OrgAbbreviation="PKIG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.3:c.10238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2373507" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="584372|MedGen:CN182502;C1704417" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001208232" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20032471</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">1431583</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr3413Metfs*2) in the APOB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in APOB are known to be pathogenic (PMID: 20032471). This variant is present in population databases (rs756209187, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with autosomal dominant hypobetalipoproteinemia (PMID: 1431583). This variant is also known as c.10366del. ClinVar contains an entry for this variant (Variation ID: 434252). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.21229502del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN182502" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1704417" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7569922" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_000384.2:c.10238del|Hypobetalipoproteinemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046197" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is also referred to as c.10366del in the literature. This frameshifting variant in exon 26 of 29 introduces a premature stop codon and is therefore predicted to result in loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay (NMD). This variant has been previously reported as a heterozygous change in patients with Hypobetalipoproteinemia (PMID: 1431583). Loss-of-function variation in APOB is an established mechanism of disease (PMID: 30939045). Experimental studies have shown that this c.10238del (p.Thr3413MetfsTer2) change results in decreased LDL-cholesterol levels and reduced APOB protein concentrations (PMID: 1431583). The c.10238del (p.Thr3413MetfsTer2) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.0007% (2/282662) and thus is presumed to be rare. Based on the available evidence, the c.10238del (p.Thr3413MetfsTer2) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.2:c.10238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hypobetalipoproteinemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9244502" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2024-05-01">
        <ClinVarSubmissionID localKey="a150166|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005034952" DateUpdated="2024-05-01" DateCreated="2024-05-01" Type="SCV" Version="1" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1431583</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33454241</ID>
          </Citation>
          <Comment>The c.10238delC pathogenic mutation, located in coding exon 26 of the APOB gene, results from a deletion of one nucleotide at nucleotide position 10238, causing a translational frameshift with a predicted alternate stop codon (p.T3413Mfs*2). This variant has been detected in the heterozygous state in individuals with low LDL cholesterol, some of whom also had fatty liver disease (Krul ES et al. J Lipid Res. 1992 Jul;33(7):1037-50; Vilar-Gomez E et al. J Clin Lipidol. 2021 Dec;15(2):275-291). One study reported this variant to result in increased LDL receptor binding (Krul ES et al. J Lipid Res. 1992 Jul;33(7):1037-50). Although biallelic loss of function alterations in APOB have been associated with autosomal recessive hypobetalipoproteinemia, haploinsufficiency for APOB has not been clearly established as a mechanism of disease for autosomal dominant familial hypercholesterolemia. Based on the supporting evidence, this variant would be expected to cause autosomal recessive hypobetalipoproteinemia when present along with a second pathogenic or likely pathogenic variant on the other allele; however, the association of this alteration with autosomal dominant familial hypercholesterolemia is unlikely.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="APOB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.2:c.10238delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9791100" SubmissionDate="2024-05-15" DateLastUpdated="2024-05-19" DateCreated="2024-05-19">
        <ClinVarSubmissionID localKey="NM_000384.2:c.10238del" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005044151" DateUpdated="2024-05-19" DateCreated="2024-05-19" Type="SCV" Version="1" SubmitterName="New York Genome Center" OrgID="507558" OrganizationCategory="laboratory" OrgAbbreviation="NYGC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32719484</ID>
          </Citation>
          <Comment>The heterozygous c.10238del variant in APOB has previously been reported in individuals with associated familial hypercholesterolemia [PMID: 32719484] and it has been deposited in ClinVar (Var ID: 434252) as Pathogenic/Likely pathogenic. The c.10238del variant is observed in 7 alleles (~0.0011% minor allele frequency with 0 homozygotes) in population databases (gnomAD v2.1.1 and v3.1.2, TOPMed Freeze 8), suggesting it is not a common benign variant in the populations represented in those databases. The c.10238del variant in APOB is located in exon 26 of this 29-exon gene, predicted to incorporate a premature termination codon (p.(Thr3413MetfsTer2)), and is expected to result in loss-of-function via nonsense mediated decay. Multiple loss-of-function variants that are downstream to the c.10238del variant have been reported in ClinVar or literature in affected individuals. Based on available evidence this inherited c.10238del, p.(Thr3413MetfsTer2) variant identified in APOB is classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">NYGC Assertion Criteria 2020</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/hhfhf6ms/nygc_assertion_criteria_2020.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="weeks gestation">30</Age>
              <Age Type="maximum" age_unit="weeks gestation">39</Age>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>NovaSeq 6000</NamePlatform>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">whole genome sequencing</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">yes</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000474" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001636" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000384.2:c.10238del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="144010" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>PrenatalSEQ</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB14405054</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5457647" TraitType="Disease" MappingType="XRef" MappingValue="144010" MappingRef="OMIM">
        <MedGen CUI="C1704417" Name="Hypercholesterolemia, autosomal dominant, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9791100" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000474" MappingRef="HP">
        <MedGen CUI="C1836940" Name="Thickened nuchal skin fold" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2373507" TraitType="Disease" MappingType="XRef" MappingValue="CN182502" MappingRef="MedGen">
        <MedGen CUI="C4551990" Name="Familial hypobetalipoproteinemia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2805170" TraitType="Disease" MappingType="XRef" MappingValue="615558" MappingRef="OMIM">
        <MedGen CUI="C4551990" Name="Familial hypobetalipoproteinemia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5457647" TraitType="Disease" MappingType="XRef" MappingValue="615558" MappingRef="OMIM">
        <MedGen CUI="C4551990" Name="Familial hypobetalipoproteinemia 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2373507" TraitType="Disease" MappingType="XRef" MappingValue="C1704417" MappingRef="MedGen">
        <MedGen CUI="C1704417" Name="Hypercholesterolemia, autosomal dominant, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1149708" TraitType="Disease" MappingType="Name" MappingValue="Hypobetalipoproteinemia" MappingRef="Preferred">
        <MedGen CUI="C0020597" Name="Hypobetalipoproteinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9791100" TraitType="Disease" MappingType="XRef" MappingValue="144010" MappingRef="OMIM">
        <MedGen CUI="C1704417" Name="Hypercholesterolemia, autosomal dominant, type B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7569922" TraitType="Disease" MappingType="Name" MappingValue="Hypobetalipoproteinemia" MappingRef="Preferred">
        <MedGen CUI="C0020597" Name="Hypobetalipoproteinemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3968337" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9791100" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001636" MappingRef="HP">
        <MedGen CUI="C0039685" Name="Tetralogy of Fallot" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9244502" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

